PROGNOSTIC AND PREDICTIVE RELEVANCE OF IMMUNOHISTOCHEMICALLY DETERMINED P53 MUTATION IN GLIOBLASTOMA

被引：0
|
作者：
Kempter, J. [1 ]
Gempt, J. [2 ]
Wiestler, B. [3 ]
Combs, S. E. [4 ]
Schlegel, J. [5 ]
Liesche-Starnecker, F. [1 ,5 ]
Schmidt-Graf, F.
机构：
[1] Tech Univ Munich, Sch Med, Dept Neurol, Munich, Germany
[2] Tech Univ Munich, Sch Med, Dept Neurosurg, Munich, Germany
[3] Tech Univ, Sch Med, Dept Diagnost & Intervent Neuroradiol, Munich, Germany
[4] Tech Univ Munich, Sch Med, Dept Radiat Oncol, Munich, Germany
[5] Tech Univ Munich, Inst Pathol, Sch Med, Dept Neuropathol, Munich, Germany
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
10.1093/neuonc/noac174.211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P11.22.A
引用
收藏
页数：1
相关论文
共 50 条
  • [21] INFLUENCE OF P53 MUTATION ON RESPONSE OF HUMAN GLIOBLASTOMA TO CYTOSTATIC TREATMENT
    Hronesova, L.
    Holacka, K.
    Polaskova, A.
    Adamik, M.
    Navratilova, L.
    Tichy, V
    Helma, R.
    Ballova, L'
    Busova, M.
    Bazantova, P.
    Fojta, M.
    Brazdova, M.
    CHEMICKE LISTY, 2013, 107 : S376 - S377
  • [22] Association Between MGMT Promoter Hypermethylation and p53 Mutation in Glioblastoma
    Shamsara, Jamal
    Sharif, Samaneh
    Afsharnezhad, Sima
    Lotfi, Marzieh
    Raziee, Hamid Reza
    Ghaffarzadegan, Kamran
    Moradi, Afshin
    Rahighi, Saeed
    Behravan, Javad
    CANCER INVESTIGATION, 2009, 27 (08) : 825 - 829
  • [23] p53 mutation and epidermal growth factor receptor overexpression in glioblastoma
    Yoon, KS
    Lee, MC
    Kang, SS
    Kim, JH
    Jung, S
    Kim, YJ
    Lee, JH
    Ahn, KY
    Lee, JS
    Cheon, JY
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (04) : 481 - 488
  • [24] The p53 Pathway in Glioblastoma
    Zhang, Ying
    Dube, Collin
    Gibert, Myron, Jr.
    Cruickshanks, Nichola
    Wang, Baomin
    Coughlan, Maeve
    Yang, Yanzhi
    Setiady, Initha
    Deveau, Ciana
    Saoud, Karim
    Grello, Cassandra
    Oxford, Madison
    Yuan, Fang
    Abounader, Roger
    CANCERS, 2018, 10 (09)
  • [25] Prognostic and predictive value of p53 and p21 in breast cancer
    Richard M. Elledge
    D. Craig Allred
    Breast Cancer Research and Treatment, 1998, 52 : 79 - 98
  • [26] Prognostic and predictive value of p53 and p21 in breast cancer
    Elledge, RM
    Allred, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 79 - 98
  • [27] Sensitivity and predictive value of criteria for p53 germline mutation screening
    Chompret, A
    Abel, A
    Stoppa-Lyonnet, D
    Brugières, L
    Pagès, S
    Feunteun, J
    Bonaïti-Pellié, C
    JOURNAL OF MEDICAL GENETICS, 2001, 38 (01) : 43 - 47
  • [28] Prognostic and predictive value of p53 in low MGMT expressing glioblastoma treated with surgery, radiation and adjuvant temozolomide chemotherapy
    Li, Shouwei
    Zhang, Wei
    Chen, Baoshi
    Jiang, Tao
    Wang, Zhongcheng
    NEUROLOGICAL RESEARCH, 2010, 32 (07) : 690 - 694
  • [29] Functional analysis of p53 gene and the prognostic impact of dominant-negative p53 mutation in endometrial cancer
    Sakuragi, N
    Watari, H
    Ebina, Y
    Yamamoto, R
    Steiner, E
    Koelbl, H
    Yano, M
    Tada, M
    Moriuchi, T
    INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (04) : 514 - 519
  • [30] Prognostic status of p53 gene mutation in canine mammary carcinoma
    Wakui, S
    Muto, T
    Yokoo, K
    Yokoo, R
    Takahashi, H
    Masaoka, T
    Hano, H
    Furusato, M
    ANTICANCER RESEARCH, 2001, 21 (1B) : 611 - 616
12345